首页> 外文期刊>PET clinics >Whole-Body MR Imaging The Novel, 'Intrinsically Hybrid,' Approach to Metastases, Myeloma, Lymphoma, in Bones and Beyond
【24h】

Whole-Body MR Imaging The Novel, 'Intrinsically Hybrid,' Approach to Metastases, Myeloma, Lymphoma, in Bones and Beyond

机译:整体MR成像新颖的“本质上杂交”转移,骨髓瘤,淋巴瘤,骨骼和超越的方法

获取原文
获取原文并翻译 | 示例
           

摘要

Since its advent almost 20 years ago, whole-body MR imaging (WB-MR imaging), using bone and visceral organ-targeting anatomic T1 and short-tau inversion recovery (STIR) sequences, has become a powerful, global tool for detecting skeletal involvement by metastases and to match or exceed available imaging standards, that is, bone scintigraphy and computed tomography (CT). The efficacy of WB-MR imaging has increased because of the development of the diffusion-weighted imaging (DWI) sequences, refinements in sequence combinations, and extension of anatomic imaging targets from the skeleton to all organs. Through its combination of anatomic and functional sequences, WB-MR imaging has become a unique, intrinsically hybrid technique, now available for use in oncology.
机译:自近20年前的出现以来,全身MR成像(WB-MR成像),使用骨骼和内脏器官靶向解剖学T1和短TAU反转恢复(搅拌)序列,已成为检测骨骼的强大的全球工具 通过转移和匹配或超过或超过可用的成像标准,即骨闪烁和计算断层扫描(CT)。 由于扩散加权成像(DWI)序列,序列组合的细化和从骨架到所有器官的骨骼成像靶标的改进,术语,WB-MR成像的疗效增加。 通过其解剖和功能序列的组合,WB-MR成像已成为一种独特的本质上混合技术,现在可用于肿瘤学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号